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Abstract: 
Background: Prescription charge regimes vary between countries but there is little research 
on how much people know about these or support values underlying them. 
Objective: To explore, in New Zealand (NZ) and England, the public’s knowledge of, and 
attitudes to, charges and whether knowledge and attitudes varied by demographic 
characteristics or by values about entitlement to public goods. 
Method: A questionnaire was developed and administered to people over 18 recruited in 
public places in NZ and England.  
Results: 451 people in NZ and 300 people in England participated. Less than half in each 
country knew the current prescription charge. In each country 62% of people were unaware 
of arrangements to protect people from excessive annual charges. Support for free or lower 
cost medicines for children, people over 65, people on low incomes, people on benefits, and 
people with chronic health problems was higher in England than in NZ. Support varied by 
participants’ demographic characteristics and, in the case of people on low incomes and 
people on benefits, by values about universal entitlements.  
Discussion: Gaps in knowledge, particularly about mechanisms to protect people from high 
costs, are concerning and may lead to people paying excessive charges. There was 
consensus about the elderly, children and the chronically ill being “deserving” of lower 
prescription charges, but people who did not believe in universal access to public goods 
appeared to see people on low incomes or benefits as less “deserving”. In general, public 
views resembled those underlying the prescription charge regime in their country.  
 
Key words: prescription charges, New Zealand, England, public views, public attitudes, 
comparative study 
  
Knowledge and attitudes to prescription charges in New Zealand and England 
 
INTRODUCTION  
 
Although governments in most industrialised countries pay most of the costs of prescription 
medicines for their citizens1, they also require citizens to contribute. Prescription charges 
generate revenue, and reduce excessive demand for and wastage of prescription medicines. 
However there is a considerable body of research and reviews2-4 showing that prescription 
charges prevent some people getting medicines they need2, 5-10, increase utilisation of other 
health services11, 12 and have a negative impact on people’s health13, 14.  Thus prescription 
charges are an important aspect of the interface between consumers and health systems, 
and experiences of being unable to pay can significantly affect people’s interactions with 
and perceptions of the health system7. Prescription charge regimes vary widely in different 
countries15, 16. This study examines two relatively similar countries, New Zealand and 
England, which currently have different approaches to prescription charges. New Zealand 
was a British settler colony, and most New Zealanders have European ancestry. Both 
countries have now ethnically diverse and New Zealand also has a significant indigenous 
population. Both countries have a health system funded predominantly through taxes and 
which aims to minimise financial barriers to healthcare. In both countries general 
practitioners (GPs) play a very significant role in providing primary healthcare, however in 
England GP visits are free, whilst in New Zealand there are significant user charges.  
In New Zealand prescription charges are low, but are (almost) universally applied. Everyone 
13 years and over pays $5 (equivalent to $3.54 USD on 1 Dec 2016) per prescription item. 
This entitles the patient to up to 3 months of a medicine. There are some other charges, for 
example for medicines that are only partially subsidised, but the standard charge for the 
great majority of medicines is $5. There is a payment ceiling of 20 items per individual or 
family per year (1 Feb- 31 Jan). After this people can obtain a Prescription Subsidy Card that 
entitles them to be exempt from the standard $5 charge17. However previous research has 
suggested that many people may continue to pay despite this18.  
In the UK, prescription charges vary by country. In Scotland, Wales and Northern Ireland 
prescriptions are free19. In England there is a standard charge, but most prescriptions are 
exempt (89.9% in 2014)20. The charge is much higher than that in New Zealand (8.20 UK 
pounds at the time of the study, which is equivalent to 10.27USD at 1/12/16)21 but is 
applied to a minority of prescriptions (and length of supply is longer (up to 6 months)). 
Exemptions are available on the basis of age (those under 16, those 16-18 in full-time 
education and those aged 60 or over), illness (those with a medical exemption certificate or 
who have a listed condition) and income (on Income Support or sometimes other benefits 
or tax credits). It is estimated that approximately half the adult population are exempted 
from charges22. As in New Zealand, there is also a system for protecting people from 
excessive annual charges. Those who require large numbers of prescriptions can purchase a 
Prescription Prepayment Certificate (PPC), that allows them to get as many prescription 
items as required, in the timeframe that they have prepaid for, reducing and capping the 
cost.23  
In NZ, apart from children, all citizens pay the same small amount for all prescriptions24. In 
England, those who may face a lot of prescription charges, either through age or ill-health 
are exempted from charges. These exemptions are very broadly applied so that, for 
example, individuals over 60 who are in very good health and take few medicines are also 
exempt from charges. In both countries there is some protection for those with poor health 
and therefore many prescription medicines in one year. 
There is little research exploring what the general population know about prescription 
charges. Knowledge of entitlement is important because it is one of the factors that 
determines whether people access social support they are entitled to25. There is also little or 
no research on whether the public support the policy approaches to prescription charges 
taken in their country, with the notable exception of Schaftheutle26. Public support for the 
policy approach in their country could be because the system of prescription charges 
reflects commonly held moral values about who is entitled to free medicines (who is 
deserving or undeserving) or how subsidies should be targetted, or it could be that citizens 
of a country come to accept the system that they have and regard it as fair. Views about 
universality of access to essential items and services may also affect views of prescription 
charges and this may or may not vary between countries. Initiatives involving public 
involvement in decision making, such as structured dialogues in Canada, and citizen’s juries 
in Australia have explored community values in relation to healthcare. In the Canadian 
process citizens opposed the introduction of user fees because of concerns about access27, 
and in Australia citizens were similarly concerned with equity28.  
 
The aim of the study was to explore, in New Zealand and England, the general public’s 
knowledge of and attitudes to prescription charges, whether this varied by demographic 
variables or by values about entitlement. An additional aim was to compare NZ and England, 
looking at whether knowledge, attitudes and their predictors were similar or different. 
 
METHODS 
A questionnaire was developed and administered to people recruited in public places in a 
range of cities and towns in New Zealand and England. 
 
Questionnaire design  
 
The questionnaire was designed to be short (2-5 minutes) and easy to administer in public 
places. The initial draft was developed by the New Zealand investigators, and then discussed 
by Skype with the England team, to identify questions which needed to be adapted for 
England (the ethnicity question and some of the prescription charges questions). The 
researchers in England then adapted these questions or response options to ensure that 
they made sense in the English setting.  
 
Participants in both countries were asked the same questions about their age, gender and 
ethnicity. Response options for ethnicity were different in each country, with each based on 
the ethnicity question used in the national census. Participants were then asked their 
occupation, and to rate their health on a five point scale.  
 
The interviewer then asked the participant how much people usually pay for a prescription 
medicine, and a question about their knowledge of the exemption arrangements in their 
country. In New Zealand this was about the Prescription Subsidy Card available after 20 
items, and in England it was about the Prescription Prepayment Certificate. Participants 
were then told the standard prescription charge in their country and asked whether they 
thought that a range of different people should pay that charge, less or nothing. They were 
then asked about the standard charge and whether they thought it should stay the same, be 
increased, or be decreased.  
 
The final question asked participants for their opinion of the statement “Everyone has the 
right to food, housing and medicine”. This item was adapted from McFarland and 
Mathews29 for use in the New Zealand Attitudes and Values Study 30. 
 
In New Zealand the initial questionnaire was pretested and adapted as necessary. Relevant 
changes were also adopted in the English version. This was pretested in England and no 
further changes were made.  
 
Interviews  
 
The questionnaire was administered to adults aged 18 years or older in public areas with 
high pedestrian traffic in 9 cities and towns around NZ in June/July 2015 and in Preston and 
Manchester in England in July 2015. Student interviewers selected locations based on their 
observations of pedestrian traffic. Interviews were conducted at a range of times in order to 
obtain a wide range of responses. These were all during working hours and daylight, to 
ensure student safety. In New Zealand researchers spent more than 35 hours and in England 
….. Researchers approached the first person they saw in the public area and after checking 
that the person was aged 18 or older, invited them to participate. If the person declined, the 
next available person was asked. Once a participant agreed to participate, they were given 
an information sheet briefly summarising the aims of the study and were given a brief verbal 
summary of the information sheet. Questions were read to participants and their answers 
were recorded in writing on the questionnaire.  
 
Analysis 
 
Data were entered into Excel (NZ) and into PSPP (England)31. Data entry was then cross 
checked by another researcher to ensure accuracy. All analyses were conducted using 
RStudio 0.99/R 3.2.232, 33. Occupations were grouped into one of five categories; Employed, 
Unemployed, Retired, Student or Homemaker, and then dummy coded (using “Employed” 
as reference). For analyses using ethnicity in England, Arabs (n=3) were excluded because of 
small group size. Ethnicity was otherwise dummy coded (England: White, NZ: Pakeha (NZ 
European) as reference). Age was dummy coded (18-24 reference), along with gender 
(female reference). Health status and responses to the value statement were treated as 
continuous predictors. (Those that strongly agreed with the values statement, and those in 
excellent health were the reference group). 
For binary outcomes (NZ: knowledge of prescription service card, and that it applied to 
families; England: awareness of prescription prepayment certificate), logistic regression was 
used. Knowledge of the prescription price was also treated as binary (knows correct 
price/does not know correct price). Linear regression was used for the Likert type (values 
statement). To analyse the relationship between demographic variables or values statement 
and opinions about what each group of people (e.g. those on benefits) should pay for 
prescriptions, “the usual charge” was coded as “1”, “a lower charge” as “2” and “free” as 
“3” to produce a quasi-interval scale where higher scores indicate stronger belief in 
entitlement to free prescription medicines. For each variable people who said they were 
“not sure” were omitted. One person who said that people on benefits should be charged 
more was recoded to “usual cost” for analysis. 
 
Ethical approval 
 
In NZ ethics approval was granted by the School of Pharmacy acting under delegated 
authority from the University of Otago Human Ethics Committee (reference number SoP09-
15). In England ethical approval was granted by the UCLAN Ethics Committee (STEMH352). 
  
RESULTS 
 
451 people completed the questionnaires in NZ, out of 678 people who were approached.  
(Response rate=67%). 300 people completed the questionnaire in England, but 
unfortunately response rate was not recorded. Participant demographics and self-rated 
health are presented in Table 1. 
 
The New Zealand and England samples were strikingly similar in terms of gender, but the 
England sample tended to be younger. In both countries the sample was a reasonably good 
representation of the population in terms of ethnicity (although in both cases there was an 
over-representation of Asian people)34. Occupations were also similar although there were 
more students in the England sample. The proportion of people rating their health status as 
fair or poor was much higher in New Zealand.  
 
Knowledge of prescription chargesIn New Zealand 46% of participants (207 people) knew 
that the usual cost was $5.00. Age, gender, ethnicity and occupation were significantly 
related to this. Those over 65 (OR = 1.9 (CI = 1.02-3.5)), NZ Europeans (OR = 1.29 (CI = 1.01-
1.65)), and those who were retired (OR = 2.98 (CI = 1.59-5.88)) were most likely to know the 
usual cost, while men were less likely than women to know the usual cost (OR = 0.64 (CI = 
0.44-0.93).  
 
In England, the majority of the participants (281 (94%)) were not aware of the exact cost of 
a prescription item. Since the charge is not a round number as it is in New Zealand a more 
flexible definition of a “correct answer” (anything between 8 pounds and 8.50 pounds) was 
used. One hundred and three people (34%) answered within this range. This broader 
definition was used in the rest of the analyses. Gender, ethnicity, and self-reported health 
status were significant. Men (OR = 0.44 (CI = 0.26-0.72), people of Asian or British Asian 
ethnicity (OR=0.05 (CI=0.25-0.97)), and people with higher self-reported health (0.60, 
CI=0.44-0.80) were the least likely to know the cost. 
 
Sixty two percent of people (279) in New Zealand did not know that they should only have 
to pay for up to 20 prescription items per year. Of those that knew this, 28% (48 people) did 
not know that this applies to a family. Age, gender, ethnicity and occupation were 
predictors. Compared to 18-24 year olds, the 45-64 age group were 1.8 times as likely to 
know about it (CI = 1.02-3.23) and those 65 years and over more than 4 times as likely to 
know about it (OR = 4.17 (2.22-8.02)). Men were also less likely to know about the subsidy 
card, with only 31% knowing compared with 43% of women. Māori (23.6%), Pacific people 
(19.4%) and Asians (27.9%) were much less likely to know about the card than NZ Europeans 
(47%). Retired participants were significantly more likely to know about the subsidy card 
(OR = 6.85 (CI = 3.63-13.62)), with 75% of them knowing about it.  
 
In England 62% of the participants (184 people) were not aware of the Prescription 
Prepayment Certificate. Age was related to being aware of this. Those aged 45-64 (OR=5.38, 
CI=2.59-11.68), and retired people (OR = 2.62(CI = 1.13-6.45)) were most likely to know 
about the PPC. Ethnicity was related to this, but not significantly, with white people being 
most likely to know about it.  
 
Values question 
 
Answers given to the question: “Do you agree or disagree with the statement: Everyone has 
the right to food, housing and medicine?” in New Zealand, England and in the New Zealand 
Values study, from which it is taken, are reported in Figure 1.  Responses from all three 
groups show a similar pattern. Larger proportions of both the NZ and England arms of this 
study strongly agreed with the statement than the NZ Values study. Larger proportions of 
our participants also chose the middle, neutral option.   
 
In NZ, responses to the values statement were significantly related to gender and ethnicity. 
Men ( = 5.8) were less likely to agree with the statement “everyone has the right to food, 
housing and medicine” compared with women ( = 6.2) (p = 0.009). Those participants 
identifying as Māori ( = 6.6) agreed with this statement more than NZ Europeans ( = 6.1) (p 
= 0.02), whereas those identifying as Pacific ( = 5.2) or Asian ( = 5.6) were less likely to 
agree (p <.001 and p = 0.02 respectively). In England, age and employment status were 
related to responses. 69% of 18-24 year olds strongly agreed with the statement compared 
to 53% and 50% in the two older categories. 89% of unemployed people compared to 60% 
of employed people strongly agreed (p=0.02).  
 
Views about prescription charges 
 
As outlined in Table 2, most participants in both countries thought that prescriptions should 
be free for children under 13, but the proportion was much higher in England. Most 
respondents in England (70%) thought that people over 65 should pay nothing compared to 
only 39% of those in New Zealand. A far greater proportion of New Zealanders thought 
people on low incomes should pay the usual prescription charge (29% vs 9%). Only 23% of 
New Zealanders but 37% of people in England thought prescriptions should be free for this 
group. A similar pattern held for people on benefits: more New Zealanders thought people 
on benefits should pay the usual charges, and more English respondents thought 
prescriptions should be free for people on benefits. Similarly, support for free prescriptions 
for people with chronic health problems was much higher in England.  
 
The majority of New Zealanders (60%) supported the current level of prescription charges in 
New Zealand. 31% thought it should be reduced, and 3% thought it should be increased. 
Fewer people in England supported the current level of prescription charges: sixty-three 
percent thought the charge should be reduced, and 1% thought it should be increased. Six 
percent in New Zealand and 11% in England were not sure. 
 
Impact of other variables on views about prescription charges 
 Table 3 shows the relationship between demographic variables and values, and views about 
which population groups should pay for prescriptions.  
In New Zealand, unemployed people were more likely to support children having cheaper 
(or free) prescriptions (M = 2.8), p = .009. Those that strongly disagreed with the values 
statement (M = 2.4) were less likely to agree that children should have cheaper 
prescriptions p = .006. Those aged 25-44 were more likely to support cheaper prescriptions 
( =2.3) (p=0.009) for the elderly. Those who strongly disagreed with the values statement 
(M = 1.5) were less likely to support cheaper prescriptions for those on benefits. (p<0.001). 
Those of Asian ( =2.1) (p=0.03), and Other ( =2.2) (p=0.03) ethnicities were more likely to 
support cheaper prescriptions for those with low incomes. The unemployed ( =2.2), (p 
=0.03) were more likely to support cheaper prescriptions for those with low incomes. Those 
that strongly disagreed with the values statement ( =1.6), were less likely to support 
cheaper prescriptions for those on benefits p=<0.03. Those of Other Ethnicities supported 
lower prescription charges for those with chronic illness ( =2.6) p=0.02).  Those in the 
poorest health (M = 1.8) were more generous p <.001.  
 
In England, those aged 45-64 ( =3.0) were unanimous in their belief that prescriptions 
should be free for children (p=0.02). British Asians were less likely to agree (  =2.8) (p=0.04). 
The mean for Black Minority Ethnic (BME) people ( =2.5) was lower, (although the number 
in this group was low) (p=<0.001). Those aged 25-44 were more likely to support cheaper 
prescriptions ( =2.8) (p=0.003) for retired people. The mean for those over 65 was 2.9 
(p=0.03). Asian/British Asian were less likely to support cheaper prescriptions for elderly 
people ( =2.6) (p=0.04). Students were less supportive of cheaper prescriptions for elderly 
people ( =2.6) (p=0.03). Those aged 45-64 ( =2.5) (p=0.001), and those over 65 ( =2.4) 
(p=0.03) were more likely to support cheaper prescriptions for those on benefits. Retired 
people ( =2.5), (p=0.009) and the unemployed ( =2.6), (p =0.02) were more likely to 
support cheaper prescriptions for those on benefits. Those that strongly disagreed with the 
values statement ( =1.8), were much less likely to support cheaper prescriptions for those 
on benefits p=<0.001. Older people (45- 64 year olds and those over 65) were more likely to 
support cheaper prescriptions for those on low incomes (p=0.02 and p=0.04). The retired 
(2.6) (p=0.004), and unemployed ( =2.7) (p=0.005), were more generous about those on 
low incomes. Those who strongly disagreed with values statement were much less likely to 
support cheaper prescriptions (p=<0.001). Those aged 45-64 were more generous ( =2.9) 
p=0.02) about cheaper prescriptions for those with chronic illnesses.  
DISCUSSION 
In each country, less than half the population knew about the usual charge for prescriptions, 
although the proportion was higher in New Zealand. In each country, the majority of people 
did not know about the system in place to protect them from high prescription charges. In 
New Zealand older people, women and NZ Europeans were more likely to know about it. In 
England older people were also the most likely to know about the system. Support for free 
prescriptions for children, older people, people on low incomes or benefits, and people with 
chronic health problems was higher in New Zealand than in England. Participants’ 
demographic characteristics were related to whether they supported free prescriptions for 
these groups. Participants’ values also affected their support for free prescriptions for 
people on low incomes and people on benefits. 
 
The limitations of the study include non-random samples. Approaching people in the street 
is likely to lead to an over-representation of some groups, and under-representation of 
others. For example, people who are home-bound would not have been included. It is 
possible that people who refused to participate may have differed from those who agreed. 
The sample included more females than males, however people from a range of ages and 
ethnic backgrounds were included. We did not ask people in England whether they were 
exempt from prescription charges (and obviously this is likely to affect their knowledge of 
charges). People may also respond differently when faced with hypothetical questions 
rather than real situations. When asking about how much different groups should pay, 
participants were not asked whether they thought any groups should pay more than they 
currently do (although they were asked whether the usual charge should be higher). In 
addition, participants were not asked how much money they thought people should pay. 
Instead answers were defined in terms of the usual copayment in each country, so “less 
than usual” in England, could be the same amount as usual in NZ. Finally, one question is not 
a comprehensive way to measure people’s values. 
 
Accurate knowledge of the cost of prescriptions items seems predictable based on the 
schemes in each country and patterns of pharmacy usage. In New Zealand older people and 
those retired were more likely to know the cost, presumably because of high prescription 
medicine use which they have to pay for. In England this was not the case because elderly 
people there do not have to pay for their medicines. In both countries men were less likely 
to know the cost, presumably because they are less likely to visit pharmacies because of 
gender roles and lower medicines use35, 36. In both countries Asians were less likely to know 
the cost, and the reason for this is unclear.  
An identical proportion of people in each country, a majority of the sample, did not know 
about the scheme designed to protect people from high prescription charges. This is 
consistent with previous qualitative research in England22 and suggests that these schemes 
may not be working well. Although such schemes should not rely entirely on patient 
knowledge to be initiated, public knowledge is important to ensure that entitlements are 
accessed by those who are eligible25. Not surprisingly, in New Zealand older people and 
retired people were more likely to know about the scheme. In England, the age group who 
are most likely to face many prescriptions charges, the 45-64 age group, were also the most 
likely to know about it. In both countries men were less likely to know about it. The findings 
by ethnicity are concerning. In both countries white participants were most likely to know 
about the scheme. Although the difference was not statistically significant in England, it was 
large and statistically significant in New Zealand. Given that Māori and Pacific people have 
lower health status and are more likely to report going without medicines because of cost5, 
this is a worrying finding. McMillan et al in Australia found that some consumers were 
unaware of how the Pharmaceutical Benefits Scheme worked and how to access higher 
prescription subsidies37. Some pharmacists who participated in McMillan et al.’s study 
reported that some consumers who should be eligible to reach the threshold for cheaper 
prescriptions missed out on this because they used various pharmacies and did not keep a 
record of all their prescriptions38. In other settings, lack of knowledge of entitlements and 
how to claim them has been identified as a problem39. Other studies have also found gaps in 
knowledge of entitlements amongst ethnic minority populations40. For example, a New 
Zealand study found that non-European New Zealanders were less likely to know about the 
meals on wheels service41. 
Predictors of values were different in each country: gender and ethnicity were important in 
NZ, age and employment status in England. Reasons for this are unclear. Support for free or 
cheaper prescriptions for any group was higher in England than in New Zealand, suggesting 
that prescription charge regime and population values align in each country. In both 
countries support was strongest for free or cheaper prescriptions for children and weakest 
for people on low incomes or benefits.  
While responses to questions about the ideal rate of prescription charges for all groups 
were influenced by demographic characteristics of respondents, responses to the values 
statement were also significant for views about how much people on benefits and people 
on low incomes should pay. Perhaps there is greater social consensus about the elderly, 
children and the chronically ill being “deserving” of greater assistance. People on low 
incomes and those on benefits might be seen as “undeserving” by people who do not 
believe in universal access to necessities of life. This results also supports the validity of this 
measure of attitudes to human rights or “Identification with all humanity” 42 
 
Conclusion 
In general people’s views in each country do appear to support the systems they have, and 
thus systems seem to reflect underlying values about entitlement. While it is not 
unexpected that people who interact most with the pharmacy system are most familiar with 
information about usual prices of medicines, it is concerning that lack of knowledge of 
entitlements is low in groups who tend to have lower health status.  
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Table 1: participant demographic data 
  New 
Zealand 
 England  
  Number Percent Number Percent 
Gender Male  193  43 132 44 
 Female 258 57 168 56 
Age 18-24 91 20 105 35 
 25-44 151 33 124 41 
 45-64 129 29 47 16 
 65+ 80 18 24 8 
Ethnicity 
(NZ)1 
New Zealand European 269 58   
 Māori 53 11   
 Pacific 31 7   
 Asian 86 19   
 Other 25 5   
Ethnicity 
(England) 
White   224 74 
 Mixed or multiple ethnicity   8 2 
 Asian or British Asian   56 19 
 Black/African/Caribbean/Black 
British 
  9 3 
 Arab or other ethnic group   3 1 
Occupation Employed 279 62 184 61 
 Retired 56 12 26 9 
 Unemployed 27 6 18 6 
 Studying 67 15 72 24 
 Homemaker 22 5   
Self-rated 
health 
1 (ie excellent) 73 16 42 14 
 2 148 33 139 46 
 3 124 27 93 31 
 4 55 13 24 8 
 5 (poor) 51 11 2 1 
 
1 The main ethnic groups identified in the New Zealand census are New Zealand European 
(New Zealanders who trace their ancestry to people from Europe), Maori (indigenous New 
Zealanders), Pacific (people who trace their ancestry to Pacific Island countries such as 
Samoa, Tonga, Fiji etc), Asian (people who trace their ancestry to Asian countries, including 
the Indian subcontinent, such as China, India, Pakistan, Vietnam), and Other ethnic groups. 
 
 
 
Figure 1: responses to the values question: “Do you agree or disagree with the statement: 
Everyone has the right to food, housing and medicine?” 
 
  
Table 2: Views about how much people should pay for prescriptions in New Zealand and 
England (% of respondents in each country) 
 Should pay the 
standard charge 
Should pay 
less 
Should get 
free 
prescriptions 
Not sure 
 NZ England NZ England NZ England NZ England 
Children under 13 
(currently free in 
both countries) 
16 1 24 9 55 88 4 2 
People over 65 
(currently free in 
England) 
31 2 26 23 39 70 4 5 
People on low 
incomes 
(currently mostly 
free in England) 
29 9 43 50 23 37 4 4 
People on benefits 
(currently mostly 
free in England) 
33 20 39 36 22 37 5 7 
People with long-
term chronic illness 
(currently mostly 
free in England) 
20 2 32 24 43 70 6 4 
 
 
 
  
Table 3: mean scores for what different population groups should pay for prescriptions 
 
 New Zealand Significantly 
related to 
England Significantly 
related to 
Children 2.4 Employment, 
values 
2.9 Age, ethnicity 
Over 65/retired 2.1 Age 2.7 Age, ethnicity, 
employment 
status 
Benefits 1.9 Values 2.2 Age, 
employment, 
values 
Low income 1.9 Ethnicity, 
employment, 
values 
2.3 Age, 
employment, 
values 
People with 
chronic illness 
2.2 Ethnicity, 
health 
2.7 Age 
 
* “the usual charge” was coded as “1”, “a lower charge” as “2” and “free” as “3” to produce 
a quasi-interval scale where higher scores indicate stronger belief in entitlement to free 
medicine. People who said they were “not sure” were excluded. 
 
